For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241129:nRSc2166Oa&default-theme=true
RNS Number : 2166O IQE PLC 29 November 2024
IQE plc
Cardiff, UK
29 November 2024
Long Term Incentive Plan (LTIP) Award
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound
semiconductor wafer products and advanced material solutions to the global
semiconductor industry, announces that on 28 November 2024, IQE's Board of
Directors has approved a recommendation made by the Remuneration Committee to
grant IQE's Interim Chief Executive Officer and Chief Financial Officer, Jutta
Meier, an award of 860,092 share options over ordinary shares of 1 pence each
in the Company ("Award") at nil cost, pursuant to IQE's Long Term Incentive
Plan. The Award is subject to a three-year performance period to 31 December
2026 (the "Performance Period").
This announcement is made in accordance with Article 19 of the EU Market Abuse
Regulation 596/2014 (as incorporated into UK domestic law by the European
Union (Withdrawal) Act 2018).
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1. Details of the Person discharging managerial responsibilities ("PDMR") /
person closely associated with them ("PCA")
a) Name Jutta Meier
2. Reason for the notification
a) Position / status Interim Chief Executive Officer & Chief Financial Officer
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name IQE plc
b) Legal Entity Identifier 213800Y33WHD3ESJJP16
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Ordinary shares of 1 pence each in the Company
GB0009619924
b) Nature of the transaction Award of options
c) Price(s) and volume(s) Price Volume
Nil 860,092
d) Aggregated information
· Aggregated volume
· Aggregated price
e) Date of the transaction(s) 28 November 2024
f) Place of the transaction Off-market
d)
Aggregated information
· Aggregated volume
· Aggregated price
e)
Date of the transaction(s)
28 November 2024
f)
Place of the transaction
Off-market
Contacts:
IQE plc
+44 (0) 29 2083 9400
Mark Cubitt
Jutta Meier
Amy Barlow
Peel Hunt (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Ben Cryer
Kate Bannatyne
Adam Telling
Numis (Joint Broker)
+44 (0) 20 7260 1000
Simon Willis
Hugo Rubinstein
Iqra Amin
Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Chloe Francklin: +44 (0)78 3497 4624
ABOUT IQE
http://iqep.com
(https://www.globenewswire.com/Tracker?data=yZf7NKp1JKLALUCxlBuC8wkLnLAqoe5-kjjIlkMIDci9q9W0x_02bwZV-eorSbpLXZxy4zi3xHh-O4FM8nWjeg==)
IQE is the leading global supplier of advanced compound semiconductor wafers
and materials solutions that enable a diverse range of applications across:
· Smart Connected Devices
· Communications Infrastructure
· Automotive and Industrial
· Aerospace and Security
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in
this market which has high barriers to entry. IQE supplies the global market
and is enabling customers to innovate at chip and OEM level. By leveraging the
Group's intellectual property portfolio including know-how and patents, it
produces epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with employees across eight manufacturing
locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in
London.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFFLLFLAFIS